[Value of the association of sulformethoxine (fanasil) and pyrimethamine in the radical treatment of malaria due to Plasmodium falciparum].
D000293:Adolescent; D000328:Adult; D002160:Cambodia; D004357:Drug Synergism; D004361:Drug Tolerance; D005260:Female; D005334:Fever; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010963:Plasmodium falciparum; D011739:Pyrimethamine / Q000009:adverse effects / Q000627:therapeutic use*; D011803:Quinine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use*
D013449:Sulfonamides; D011803:Quinine; D011739:Pyrimethamine
Intérêt de l'association de la sulforméthoxine (fanasil) et de la pyriméthamine dans la cure radicale du paludisme a Plasmodium falciparium.